Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Qi Yan Nan"'
Autor:
Jun Ding, Sheng Cui, Song Yu Li, Lin Yan Cui, Qi Yan Nan, Xue Jing Lin, Mei Ying Xuan, Jian Jin, Shang Guo Piao, Yu Ji Jiang, Hai Lan Zheng, Ji Zhe Jin, Byung Ha Chung, Chul Woo Yang, Jing Hao Cui, Can Li
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0286903 (2023)
The angiotensin receptor neprilysin inhibitor LCZ696 affords superior cardioprotection and renoprotection compared with renin-angiotensin blockade monotherapy, but the underlying mechanisms remain elusive. Herein, we evaluated whether LCZ696 attenuat
Externí odkaz:
https://doaj.org/article/0a4c6b0f22f54818a37aba4d653ff9db
Autor:
Yu Ji Jiang, Sheng Cui, Kang Luo, Jun Ding, Qi Yan Nan, Shang Guo Piao, Mei Ying Xuan, Hai Lan Zheng, Yong Jie Jin, Ji Zhe Jin, Jung Pyo Lee, Byung Ha Chung, Bum Soon Choi, Chul Woo Yang, Can Li
Publikováno v:
The Korean Journal of Internal Medicine, Vol 36, Iss 6, Pp 1437-1449 (2021)
Background/Aims Cigarette smoking is an important modifiable risk factor in kidney disease progression. However, the underlying mechanisms for this are lacking. This study aimed to assess whether nicotine (NIC), a major toxic component of cigarette s
Externí odkaz:
https://doaj.org/article/8f4db247e3324446ad59a322ddc478e4
Autor:
Shang Guo Piao, Jun Ding, Xue Jing Lin, Qi Yan Nan, Mei Ying Xuan, Yu Ji Jiang, Hai Lan Zheng, Ji Zhe Jin, Can Li
Publikováno v:
PLoS ONE, Vol 17, Iss 10 (2022)
Renal fibrosis represents the final common outcome of chronic kidney disease of virtually any etiology. However, the mechanism underlying the evolution of renal fibrosis remains to be addressed. This study sought to clarify whether RIP1-RIP3-mediated
Externí odkaz:
https://doaj.org/article/c57032bcf7a14557915c0b7b13cb6873
Autor:
Mei Ying Xuan, Shang Guo Piao, Jun Ding, Qi Yan Nan, Mei Hua Piao, Yu Ji Jiang, Hai Lan Zheng, Ji Zhe Jin, Can Li
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, offers renoprotection in diabetes. However, potential for use in nondiabetic kidney disease remains unknown. Herein, we assessed whether dapagliflozin alleviates renal fibrosis by interfering
Externí odkaz:
https://doaj.org/article/6933e60df2a24671b07ba9df63453efa
Autor:
Yong Jie Jin, Qi Yan Nan, Mei Ying Xuan, Can Li, Jung Pyo Lee, Hai Lan Zheng, Sheng Cui, Kang Luo, Jun Ding, Byung Ha Chung, Shang Guo Piao, Bum Soon Choi, Yu Ji Jiang, Ji Zhe Jin, Chul Woo Yang
Publikováno v:
The Korean Journal of Internal Medicine, Vol 36, Iss 6, Pp 1437-1449 (2021)
The Korean Journal of Internal Medicine
The Korean Journal of Internal Medicine
Background/Aims: Cigarette smoking is an important modifiable risk factor in kidney disease progression. However, the underlying mechanisms for this are lacking. This study aimed to assess whether nicotine (NIC), a major toxic component of cigarette
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5233bff2186877715dbe112901fc0f5
http://www.kjim.org/upload/pdf/kjim-2021-326.pdf
http://www.kjim.org/upload/pdf/kjim-2021-326.pdf
Autor:
Shang Guo Piao, Jun Ding, Xue Jing Lin, Qi Yan Nan, Mei Ying Xuan, Yu Ji Jiang, Hai Lan Zheng, Ji Zhe Jin, Can Li
Publikováno v:
PloS one. 17(10)
Renal fibrosis represents the final common outcome of chronic kidney disease of virtually any etiology. However, the mechanism underlying the evolution of renal fibrosis remains to be addressed. This study sought to clarify whether RIP1-RIP3-mediated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62615ac04b400a4a5964ef99a32b5132
https://pubmed.ncbi.nlm.nih.gov/36223414
https://pubmed.ncbi.nlm.nih.gov/36223414
Autor:
Mei Ying Xuan, Shang Guo Piao, Jun Ding, Qi Yan Nan, Mei Hua Piao, Yu Ji Jiang, Hai Lan Zheng, Ji Zhe Jin, Can Li
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2022)
Frontiers in Pharmacology, Vol 12 (2022)
Dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, offers renoprotection in diabetes. However, potential for use in nondiabetic kidney disease remains unknown. Herein, we assessed whether dapagliflozin alleviates renal fibrosis by interfering
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ee1d5dae8bec8fc5c7ee962f2a0ad4a
https://pubmed.ncbi.nlm.nih.gov/35069210
https://pubmed.ncbi.nlm.nih.gov/35069210
Autor:
Yu Ji Jiang, Jian Jin, Qi Yan Nan, Jun Ding, Sheng Cui, Mei Ying Xuan, Mei Hua Piao, Shang Guo Piao, Hai Lan Zheng, Ji Zhe Jin, Byung Ha Chung, Chul Woo Yang, Can Li
Publikováno v:
International Immunopharmacology. 108:108868
Coenzyme Q10 (CoQ10) protects against various types of injury, but its role in preventing renal scarring in chronic kidney disease remains an open question. Herein, we evaluated whether CoQ10 attenuates renal fibrosis by interfering with necroinflamm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::875321ad310e6ef479282d44390264a5
https://doi.org/10.1016/j.intimp.2022.108868
https://doi.org/10.1016/j.intimp.2022.108868
Autor:
QI Yan-nan, LüCheng-xu, ZHANG Jun-ning, LI Ya-shuo, ZENG Zhen, MAO Wen-hua, JIANG Han-lu, YANG Bing-nan
Publikováno v:
Proceedings of SPIE; 5/6/2018, Vol. 10697, p1-18, 18p
Autor:
Jin, Weiqi, Li, Ye, Qi, Yan-nan, Lü, Cheng-xu, Zhang, Jun-ning, Li, Ya-shuo, Zeng, Zhen, Mao, Wen-hua, Jiang, Han-lu, Yang, Bing-nan
Publikováno v:
Proceedings of SPIE; February 2018, Vol. 10697 Issue: 1 p106972D-106972D-18, 10590247p